Four Forces Disrupting DSO Growth in 2026: PE, Integration, AI, and Diagnostics
Four major forces are reshaping DSO growth in 2026, according to Becker’s Dental Review. Private equity investment is resurging, especially in oral surgery — the only dental specialty that increased PE deal volume in 2025, up 9.1% year over year. Medical-dental integration is expanding as DSOs partner with health systems to share electronic health records and co-locate care. Artificial intelligence is being adopted at scale across patient communication, diagnostics, and operations at major networks including Sonrava Health, Aspen Dental, and Heartland Dental. Salivary diagnostics is emerging as a clinical frontier, enabling DSOs to reposition dentists as oral physicians within broader healthcare ecosystems — with potential reimbursement and differentiation advantages in competitive local markets.
For DSO growth teams and PE investors, this signals where capital and clinical energy are concentrating in 2026. Medical-dental integration and AI adoption are becoming table stakes for enterprise positioning, while salivary diagnostics could unlock new reimbursement pathways and meaningful differentiation in competitive local markets.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.